EUVIMEDEUVIMED entdecken
Crossref

Prenatal dexamethasone partially rescues renal tubular dysgenesis in a germline Agt -deletion mouse model

Shih-Hua Lin, Martin Konrad, Shih-Ming Huang, Jhao-Jhuang Ding, Min-Hua Tseng

Journal of the Renin-Angiotensin-Aldosterone System · 2026-11 · 27

DOI: 10.1177/14703203261506675 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Renin-Angiotensin-Aldosterone System, online erschienen am 11.11.2026. Verfasst von Shih-Hua Lin und 4 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Chang Gung Memorial Hospital, Linkou, Hsinchu Science Park Bureau, Ministry of Science and Technology, Taiwan.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypothesis/Introduction Given higher neonatal mortality associated with autosomal recessive renal tubular dysgenesis (ARRTD), this study investigated the role of AGT mutations and evaluated the therapeutic efficacy of prenatal dexamethasone. Materials and Methods A germline Agt exon 3–4 deletion mouse model bearing a 2791-bp deletion encompassing exons 3 and 4 was generated. Eleven mice (3 wild-type, 4 heterozygous, 4 homozygous) underwent phenotyping at 24 weeks. Pregnant heterozygous dams received subcutaneous dexamethasone (1 mg/kg/day) or vehicle, and offspring were analysed at postnatal day 1 by quantitative RT-PCR, immunoblotting, ELISA and Lotus Tetragonolobus Lectin (LTL) immunofluorescence. Groups were compared by Student's two-tailed t test.

Results

Agt ΔE3–4/ΔE3–4 mice exhibited hypotension, elevated serum creatinine and urea, high postnatal mortality and impaired urine concentration. Histology revealed defective proximal tubular development. Hepatic Agt mRNA was near-undetectable and hepatic AGT protein markedly reduced, accompanied by decreased circulating AGT and angiotensin II and increased renin. Prenatal dexamethasone enhanced hepatic AGT production, reduced renin, and partially restored proximal tubule maturation.

Conclusions

This study shows AGT is crucial for maintaining renin-angiotensin system homeostasis and supporting normal kidney development, and provides in vivo evidence that prenatal dexamethasone can partially reverse the fatal renal and molecular defects caused by AGT mutation-induced ARRTD.

Förderung

  • Chang Gung Memorial Hospital, Linkou
  • Hsinchu Science Park Bureau, Ministry of Science and Technology, Taiwan

Zitieren

APA

Lin, S., Konrad, M., Huang, S., Ding, J., & Tseng, M. (2026). Prenatal dexamethasone partially rescues renal tubular dysgenesis in a germline Agt -deletion mouse model. Journal of the Renin-Angiotensin-Aldosterone System, 27. https://doi.org/10.1177/14703203261506675

Vancouver

Lin S, Konrad M, Huang S, Ding J, Tseng M. Prenatal dexamethasone partially rescues renal tubular dysgenesis in a germline Agt -deletion mouse model. Journal of the Renin-Angiotensin-Aldosterone System. 2026;27. doi:10.1177/14703203261506675

BibTeX
@article{Lin2026,
  author = {Lin, Shih-Hua and Konrad, Martin and Huang, Shih-Ming and Ding, Jhao-Jhuang and Tseng, Min-Hua},
  title = {Prenatal dexamethasone partially rescues renal tubular dysgenesis in a germline Agt -deletion mouse model},
  journal = {Journal of the Renin-Angiotensin-Aldosterone System},
  year = {2026},
  volume = {27},
  doi = {10.1177/14703203261506675}
}
Kostenlos starten →